Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have made the differentiation between adenocarcinoma and squamous cell carcinoma increasingly important. Pathologists are challenged to make the correct diagnosis in small specimens. We studied the accuracy...
Main Authors: | Fabiola Del Carlo Bernardi, Marcela Del Carlo Bernardi, Teresa Takagaki, Sheila Aparecida Coelho Siqueira, Marisa Dolhnikoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2018-10-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322018000100278&lng=en&tlng=en |
Similar Items
-
Diagnostic Value of Immunohistochemistry Panel of P63, CK5/6, TTF1, NapsinA in the Diagnosis of Adenocarcinoma and Squamous Cell Carcinoma of Lung
by: Tahereh Mohsenian Sisakht, et al.
Published: (2020-07-01) -
Expression and Clinical Significance of TTF-1 and p63 in NSCLC
by: Peng ZHANG, et al.
Published: (2009-09-01) -
Subtyping of Non-Small Cell Lung Carcinomas in Bronchoscopic Biopsies: A Tertiary Care Centre Experience
by: Mihir Mohan Vaidya, et al.
Published: (2018-11-01) -
Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer
by: Alice Court, et al.
Published: (2022-06-01) -
Role Of TTF-1, CK20, And CK7 Immunohistochemistry for Diagnosis of Primary and Secondary Lung Adenocarcinoma
by: Yue-Chiu Su, et al.
Published: (2006-01-01)